(PharmaNewsWire.Com, May 03, 2017 ) According to Publisher, the Global Apheresis Equipment market is accounted for $1.42 billion in 2016 and is expected to reach $3.37 billion by 2022 growing at a CAGR of 15.4% from 2016 to 2022. Increasing incidence of cardiovascular disorders, demand for automated blood component separation procedures, adoption of technologically advanced automated products, government focusing on healthcare infrastructure and rise in the number of platelet donors are fueling the market growth. However, histocompatibility issues, high cost of equipment and lack of trained technicians will hamper market growth.
Plasmapheresis segment accounted for the largest market share of the apheresis procedure market due to growing incidence of hematological disorders. Apheresis disposable kits is the largest segment in the total apheresis equipment product market as single use products are in high demand along with high usage volume. Neurology segment is projected to witness the fastest growth under application as individuals are affected with multiple sclerosis. North America is the leading market because of the presence of sophisticated healthcare infrastructure. Asia Pacific is anticipated to be the fastest growing market due to Increasing prevalence of blood disorders and plasma products in China, Japan, Australia, Korea and India.
Some of the key players in global Apheresis Equipment market are Asahi Kasei Kuraray Medical Co., Ltd., Fenwal, Inc., Braun Melsungen AG, Cerus Corporation, Fresenius Se & Co. KGAA, Medica SpA, Kaneka Corporation, Nikkiso Co., Ltd, Kawasumi Laboratories Inc, Therakos, Inc., HemaCare Corporation, Haemonetics Corporation and Terumo BCT, Inc.
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific -Rest of the World -Middle East -Brazil -Argentina -South Africa -Egypt
Company Profiling 11.1 Asahi Kasei Kuraray Medical Co., Ltd. 11.2 Fenwal, Inc. 11.3 B Braun Melsungen AG 11.4 Cerus Corporation 11.5 Fresenius Se & Co. KGAA 11.6 Medica SpA 11.7 Kaneka Corporation 11.8 Nikkiso Co., Ltd 11.9 Kawasumi Laboratories Inc 11.10 Therakos, Inc. 11.11 HemaCare Corporation 11.12 Haemonetics Corporation 11.13 Terumo BCT, Inc.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
